Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical atherosclerosis.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  International Journal of Cardiology

• Publication date

  2018-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2017.07.026PMID 28728850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.

  2017cited by this paper
• Changes in cardiovascular disease risk and behavioural risk factors before the introduction of a health check programme in England.

  2016cited by this paper
• Temporal Trends in Clinical Outcomes Following Percutaneous Coronary Intervention in Patients with Renal Insufficiency

  2016cited by this paper
• Lifestyle and risk factor management in people at high cardiovascular risk from Bulgaria, Croatia, Poland, Romania and the United Kingdom who participated in both the EUROASPIRE III and IV primary care surveys

  2016cited by this paper
• 2015 Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines - Executive Summary

  2016cited by this paper
• 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.

  2016cited by this paper
• Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.

  2015cited by this paper
• Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention.

  2015cited by this paper
• The burden of disease in Spain: results from the global burden of disease study 2010

  2014cited by this paper
• 2013 ACC/AHA guideline on the assessment of cardiovascular risk.

  2014cited by this paper
• 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2014cited by this paper
• Explaining trends in Scottish coronary heart disease mortality between 2000 and 2010 using IMPACTSEC model: retrospective analysis using routine data

  2014cited by this paper
• Original Research Put Into Perspective for the Practicing Clinician

  2014cited by this paper
• 30-year trends in patient characteristics, treatment practices, and long-term outcomes of adults aged 35 to 54 years hospitalized with acute myocardial infarction.

  2014cited by this paper
• Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey.

  2013cited by this paper
• Total atherosclerotic burden by whole body magnetic resonance angiography predicts major adverse cardiovascular events.

  2013cited by this paper
• ESC/EAS Guidelines for the Management of Dyslipidaemias

  2013cited by this paper
• Estimating Equations for Glomerular Filtration Rate in the Era of Creatinine Standardization

  2012cited by this paper
• Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

  2012cited by this paper
• Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review.

  2012cited by this paper
• Reductions in risk factors for secondary prevention of coronary heart disease by ethnic group in south-west London: 10-year longitudinal study (1998-2007).

  2010cited by this paper
• 2007 Guidelines for the management of arterial hypertension

  2007cited by this paper
• 2013 ESH/ESC Guidelines for the management of arterial hypertension

  2007cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• Trends in lifestyle factors affecting blood pressure in hypertensive and normotensive Finns during 1982–2002

  2007cited by this paper
• The Changing Risk Factor Profile of Participants Enrolled in a Secondary Stroke Prevention Trial: Vitamin Intervention for Stroke Prevention

  2006cited by this paper
• Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population.

  2004cited by this paper
• Explaining the Decline in Coronary Heart Disease Mortality in England and Wales Between 1981 and 2000

  2004cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

  2003cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

  2003cited by this paper
• Long-term trends in the incidence of and survival with heart failure.

  2002cited by this paper
• Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III.

  2000cited by this paper
• Explanation for the Decline in Coronary Heart Disease Mortality Rates in Auckland, New Zealand, Between 1982 and 1993

  2000cited by this paper
• A systematic review of troponin T and I for diagnosing acute myocardial infarction.

  2000cited by this paper
• Second Manifestations of ARTerial disease (SMART) study: Rationale and design

  1999cited by this paper
• Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994

  1999cited by this paper
• Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.

  1998cited by this paper
• Design and methods

  1994cited by this paper
• Risk factors and atherosclerotic lesions. A review of autopsy studies.

  1983cited by this paper

• Impact of the 2021 ESC Prevention Guideline's stepwise approach for cardiovascular risk factor treatment in patients with established ASCVD.

  2024cites this paper
• In RA patients without prevalent CVD, incident CVD is mainly associated with traditional risk factors: A 20-year follow-up in the CARRÉ cohort study.

  2022cites this paper
• High levels of risk factors and poor secondary prevention for coronary heart disease patients in public hospitals: A descriptive repeated measures study.

  2022cites this paper
• Risk Factor Clusters and Cardiovascular Disease in High-Risk Patients: The UCC-SMART Study

  2021cites this paper
• Predicting 10-year risk of recurrent cardiovascular events andcardiovascular interventions in patients with established cardiovascular disease: results from UCC-SMART and REACH.

  2020cites this paper
• Serum microRNA-204 levels are associated with long-term cardiovascular disease risk based on the Framingham risk score in patients with type 2 diabetes: results from an observational study

  2020cites this paper
• Cholesterol induced heart valve inflammation and injury: efficacy of cholesterol lowering treatment

  2020cites this paper
• Fall in the Proportion of Atherothrombotic Strokes During the Last Decade.

  2020cites this paper
• Carotid intima-media thickness and metabolic syndrome in a rural population: Results from the Baependi Heart Study

  2020cites this paper
• Screening for abdominal aortic aneurysm in patients with clinically manifest vascular disease.

  2020cites this paper
• Incidence of and Risk Factors for Recurrent Cardiovascular Disease Events in Middle-Eastern Adults

  2019cites this paper
• Association between serum adropin and subclinical atherosclerosis in patients with hyperlipidemia

  2019cites this paper
• Data mining information from EHRs produced high yield and accuracy for current smoking status.

  2019cites this paper
• Incidence and risk factors for recurrent cardiovascular disease in middle-eastern adults: a retrospective study

  2019cites this paper
• Évaluation de la tension artérielle et de la pression du pouls dans le syndrome métabolique

  2018cites this paper
• Investigating known and novel biomarkers for risk stratification in cardiovascular disease

  2018cites this paper
• Electroacupuncture ameliorates poloxamer 407‐induced hyperlipidemia through suppressing hepatic SREBP‐2 expression in rats

  2018cites this paper